FindTrial
Sign In

Prone Positioning vs. Prone Positioning and NO Inhalation in COVID-19 ARDS.

Prone Positioning Versus Prone Positioning and NO Inhalation in COVID-19 Associated Acute Respiratory Distress Syndrome.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05715788
Enrollment
30
Registered
2023-02-08
Start date
2022-12-21
Completion date
2023-12-31
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome

Brief summary

The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS.

Detailed description

The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS. Patients with COVID-19-associated ARDS were ventilated in prone position with or without NO inhalation, the arterial blood gas (ABG) tests were performed at 16 hours after prone positioning.

Interventions

DRUGNitric oxide

Nitric oxide inhalation at 20 ppm

BEHAVIORALprone positioning

vatilation in prone position

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients with COVID-19 associated ARDS

Exclusion criteria

* patients who have contraindication for prone positioning, including pregnant, post-abdomen surgery within a week; hypercapnic respiratory failure

Design outcomes

Primary

MeasureTime frameDescription
P/F ratio16 hoursP/F ratios in each group

Countries

China

Contacts

Primary ContactMing Zhong, PhD
zhong.ming@zs-hospital.sh.cn‭(021) 6564 2662‬

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026